🇺🇸 TANDEM DIABETES CARE INCTNDM
Get TANDEM DIABETES CARE INC filings on Telegram the moment they are published.
Follow TANDEM DIABETES CARE INC on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 8-K Items 8.01
Overview: Received FDA 510(k) clearance for Tandem Mobi tubeless cartridge and infusion set, with a planned U.S. commercial launch in the first half of 2027.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest